Maurizio Martelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic	BONE MARROW TRANSPLANTATION	2023
Validation of imatinib therapy failure score (IMTF) in chronic phase chronic myeloid leukemia in real life practice	LEUKEMIA & LYMPHOMA	2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study	THE LANCET	2023
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels	BLOOD CELLS, MOLECULES, & DISEASES	2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2023
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed	BLOOD TRANSFUSION	2023
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome	BRITISH JOURNAL OF HAEMATOLOGY	2023
Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric Experience	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort	EUROPEAN JOURNAL OF HAEMATOLOGY	2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS	FRONTIERS IN ONCOLOGY	2023
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	EXPERT REVIEW OF HEMATOLOGY	2022
Bing-Neel syndrome coexisting with oligodendroglioma	LEUKEMIA & LYMPHOMA	2022
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL)	LEUKEMIA & LYMPHOMA	2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases	HEMATOLOGICAL ONCOLOGY	2022
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study	ADVANCES IN HEMATOLOGY	2022
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design	LEUKEMIA & LYMPHOMA	2022
Future Management of Chronic Myeloid Leukemia: From Dose Optimization to New Agents	CURRENT CANCER DRUG TARGETS	2022
Reduced Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY	2022